48,830
edits
(→Ductal carcinoma in situ: +ADH) |
|||
Line 50: | Line 50: | ||
*Invasive ductal carcinoma - excision with sentinel lymph node biopsy (for staging)<ref>Sentinel Lymph Node Biopsy: What Breast Cancer Patients Need to Know. cancernews.com. URL: [http://www.cancernews.com/data/Article/202.asp http://www.cancernews.com/data/Article/202.asp]. Accessed on: 9 October 2009.</ref> and radiation. | *Invasive ductal carcinoma - excision with sentinel lymph node biopsy (for staging)<ref>Sentinel Lymph Node Biopsy: What Breast Cancer Patients Need to Know. cancernews.com. URL: [http://www.cancernews.com/data/Article/202.asp http://www.cancernews.com/data/Article/202.asp]. Accessed on: 9 October 2009.</ref> and radiation. | ||
*Positive sentinel node - systemic chemotherapy. (???) | *Positive sentinel node - systemic chemotherapy. (???) | ||
==Atypical ductal hyperplasia== | |||
*Abbreviated ''ADH''. | |||
===General=== | |||
*Molecular studies have shown it is the same thing as low-grade DCIS; thus, some have called for abolition of the term.<ref>{{Cite journal | last1 = Ghofrani | first1 = M. | last2 = Tapia | first2 = B. | last3 = Tavassoli | first3 = FA. | title = Discrepancies in the diagnosis of intraductal proliferative lesions of the breast and its management implications: results of a multinational survey. | journal = Virchows Arch | volume = 449 | issue = 6 | pages = 609-16 | month = Dec | year = 2006 | doi = 10.1007/s00428-006-0245-y | PMID = 17058097 }}</ref> | |||
===Microscopic=== | |||
Features: | |||
*Cytologic and architectural featurs same as low-grade DCIS. | |||
*Limited extent - either:<ref>{{Ref DCHH|258}}</ref> | |||
*#< Two complete ducts. | |||
*#< 2 mm. | |||
==Ductal carcinoma in situ== | ==Ductal carcinoma in situ== |
edits